Featured Research

from universities, journals, and other organizations

Light Waves Can Detect Alzheimer's Disease Early On, Study Suggests

Date:
March 17, 2008
Source:
Optical Society of America
Summary:
Researchers have developed a way of examining brain tissue with near-infrared light to detect signs of Alzheimer's disease. The new technique may help identify ways to predict and prevent deadly disease.

A team of researchers in Bedford, Mass. has developed a way of examining brain tissue with near-infrared light to detect signs of Alzheimer's disease.

In the journal Optics Letters, the team describes how they used optical technology to examine tissue samples taken from different autopsies and correctly identified which samples came from people who had Alzheimer's disease. Alzheimer's currently afflicts some 4.5 million Americans and is the most common cause of dementia among older people in the United States.

"We're primarily interested in finding a way of diagnosing and monitoring Alzheimer's disease during life," says U.S. Department of Veterans Affairs Research Scientist Eugene Hanlon. "We think this technique has a lot of potential for detecting the disease early on."

The new technique developed by Hanlon and his collaborators at Harvard Medical School/Beth Israel Deaconess Medical Center and Boston University can detect alterations to the optical properties of the brain that occur as the tissue undergoes microscopic changes due to Alzheimer's--sometimes far in advance of clinical symptoms. The technique is now being tested for its effectiveness at diagnosing Alzheimer's disease in living people.

For several years, Hanlon and his colleagues have looked at the possibility of analyzing the brain with near-infrared light, which has the advantage of being able to safely penetrate the skull and pass harmlessly through the brain. Inside the head, some of the infrared light scatters, however, and how the light scatters can tell researchers about the condition of the brain.

In their paper, the team reports observing an optical effect due to the presence of microscopic features of Alzheimer's. Amyloid plaques, one of the telltale signs of Alzheimer's disease, scatter light differently from normal brain tissue. What Hanlon and his colleagues showed was that as the microscopic plaques accumulate, the optical properties of the brain change. The team found that this change is detectable and that their technique could quantify differences between in-vitro samples and correctly identify signs of Alzheimer's.

This technique will be a boon to medicine if it is able to detect microscopic changes that can be related to disease progression. While techniques like MRI are good at identifying the gross anatomical features associated with Alzheimer's, they cannot detect more microscopic changes.

Although Alzheimer's disease is one of the leading causes of death in the United States, claiming tens of thousands of American lives a year, there is no definitive way to diagnose it--at least not while someone is alive. After someone with Alzheimer's dies, pathologists can perform an autopsy and examine slices of the brain under the microscope, looking for the same signs that Alois Alzheimer first recognized when he identified the disease more than a century ago. Finding accumulations of amyloid plaques in the brain substance and tangle-like proteins in nerve cells is the only way to confirm with certainty that someone had Alzheimer's while they were alive.

Since there is no way to safely examine the brains of living people this way, doctors currently diagnose Alzheimer's disease using other methods. They rely on reviewing medical histories, administering physical exams, and taking into account the results of a battery of neuropsychological assessments that measure cognitive performance. A positive diagnosis is made when all other possible causes have been eliminated, but even under the best of circumstances, these diagnoses can be incorrect 10 percent of the time or more.

Accurate, early detection of Alzheimer's could save many lives. While there is no cure for the disease, clinically proven treatments can slow its progress--especially if they are administered early on. Moreover, being able to follow the disease progression over time would greatly enhance the ability of researchers and pharmaceutical companies to find new and improved drugs and treatment strategies for people at all stages of the disease.

A current rich area of research seeks to get information about what is going on in the brain without actually looking at the tissue. Some scientists, for instance, look at whether proteins and other biomarkers in the blood or spinal fluid indicate disease progression. Others try to image the brain with established techniques like MRI or PET scans. Optical methods, like the one used by the Bedford researchers, are an emerging approach to imaging.

The research was funded by the U.S. Department of Veterans Affairs, the National Science Foundation, and a New Concept Award from the Center for Integration of Medicine & Innovative Technology.

Journal reference: "Scattering Differentiates Alzheimer Disease In Vitro," by Eugene B. Hanlon et al., Optics Letters, Vol. 33, No. 6, March 15, pp. 624-26, abstract at http://www.opticsinfobase.org/abstract.cfm?URI=ol-33-6-624.


Story Source:

The above story is based on materials provided by Optical Society of America. Note: Materials may be edited for content and length.


Cite This Page:

Optical Society of America. "Light Waves Can Detect Alzheimer's Disease Early On, Study Suggests." ScienceDaily. ScienceDaily, 17 March 2008. <www.sciencedaily.com/releases/2008/03/080314164122.htm>.
Optical Society of America. (2008, March 17). Light Waves Can Detect Alzheimer's Disease Early On, Study Suggests. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2008/03/080314164122.htm
Optical Society of America. "Light Waves Can Detect Alzheimer's Disease Early On, Study Suggests." ScienceDaily. www.sciencedaily.com/releases/2008/03/080314164122.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins